Cas:110960-73-1 Ethyl 4-methylpyrimidine-5-carboxylate manufacturer & supplier

We serve Chemical Name:Ethyl 4-methylpyrimidine-5-carboxylate CAS:110960-73-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Ethyl 4-methylpyrimidine-5-carboxylate

Chemical Name:Ethyl 4-methylpyrimidine-5-carboxylate
CAS.NO:110960-73-1
Synonyms:Ethyl 4-Methylpyrimidine-5-carboxylate;5-Pyrimidinecarboxylic acid, 4-methyl-, ethyl ester;Ethyl 4-methyl-5-pyrimidinecarboxylate
Molecular Formula:C8H10N2O2
Molecular Weight:166.177
HS Code:2933599090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:251.2±20.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.508
PSA:52.08000
Exact Mass:166.074234
LogP:1.00

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Ethyl 4-Methylpyrimidine-5-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ethyl 4-methyl-5-pyrimidinecarboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Ethyl 4-Methylpyrimidine-5-carboxylate Use and application,5-Pyrimidinecarboxylic acid, 4-methyl-, ethyl ester technical grade,usp/ep/jp grade.


Related News: CDMOs closely work with companies who want to pursue upcoming innovations in medicines, help cope with shortcomings of internal lab-to-manufacturing scale-up. 1,3-bis(2-chloroethyl)-1-nitrosourea-2-(13)C=O,(15)N=O manufacturers Moderna filed an application with the FDA for that same younger age group on June 10 but has yet to hear from the agency. States like Rhode Island have already signed off on allowing 12 to 17-year-olds to use the vaccine. Poly[[hexahydro-5-[4-[[[5-methyl-4-[2-(2-methyl-5-phenyl-3-thienyl)-1-cyclopenten-1-yl]-2-thienyl]carbonyl]oxy]phenyl]-4,6-dioxo-1H-furo[3,4-c]pyrrole-1,3-diyl]-1,2-ethenediyl] suppliers “We were all surprised by the speed at which the oncology market grew in China,” Dunoyer said on the call. “Even if we don’t expect rare disease to grow at the same speed, it is likely that the speed at which the rare disease grows in China is going to be faster than other markets of the world.” N-[7-tert-Butyl-2,3-dihydro-3,3-dimethyl-benzo[b]furan-5-yl]-N-[N-ethylamidino]-N’-ethylguanidine vendor & factory.